新型疫苗技术的对比比较带来了一个充满挑战的雷区
1Adjuvant Systems Research & Development, Croda Pharma, 2800 Lyngby, Denmark.
Pharmaceutics
|January 26, 2024
概括
现代疫苗开发在选择最佳平台方面面临着挑战. 标准的临床前方案忽略了新型疫苗技术的不同抗原剂量,主要提升和时间需求,阻碍了知情选择.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 疫苗开发的最新进展引入了新的子单位技术.
- 相互对比的研究对于选择最佳的疫苗平台至关重要.
- 目前的临床前研究经常使用非优化的标准协议来选择平台.
研究的目的:
- 强调在疫苗平台选择中需要优化协议的需要.
- 讨论了解疫苗启动动力学,抗原剂量和采样时间的重要性.
- 倡导在选择疫苗技术时建立知情基础.
主要方法:
- 讨论优化疫苗平台技术的机会.
- 对疫苗启动动力学的分析.
- 考虑最佳的抗原剂量和采样时间/地点.
主要成果:
- 临床前研究往往无法优化个人新型疫苗技术的协议.
- 标准协议不考虑不同的最佳抗原剂量比率,主要增强疗法和免疫反应峰值时间点.
- 这种非优化的方法阻碍了知情的疫苗平台选择.
结论:
- 优化疫苗平台选择需要对个体疫苗特征有更深入的了解.
- 定制抗原剂量,主要提升时间表和免疫采样协议是必不可少的.
- 基于优化临床前研究的知情选择将推动现代疫苗学.
更多相关视频
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.3K
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
1.9K
相关概念视频
Vaccinations
44.5K
Overview
44.5K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
